Scarica l'app Stockscreener
44.33
7.19%
-3.43
Precedente Chiudi:
$47.76
Aprire:
$47.18
Volume 24 ore:
551.48K
Relative Volume:
0.35
Capitalizzazione di mercato:
$4.52B
Reddito:
$47.30M
Utile/perdita netta:
$-225.97M
Rapporto P/E:
-18.86
EPS:
-2.35
Flusso di cassa netto:
$-188.86M
1 W Prestazione:
-1.43%
1M Prestazione:
-3.41%
6M Prestazione:
+11.62%
1 anno Prestazione:
-2.37%
Intervallo 1D:
$44.07
$48.28
Intervallo di 1 settimana:
$43.25
$48.28
Portata 52W:
$22.71
$48.28
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Nome
Scholar Rock Holding Corp
Settore
Industria
Telefono
857-259-3860
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Confronta SRRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
44.33 | 4.87B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.88 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.28 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
815.84 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
358.80 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
341.79 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Iniziato | Citigroup | Buy |
| 2025-11-18 | Iniziato | Wolfe Research | Outperform |
| 2025-10-09 | Iniziato | BofA Securities | Buy |
| 2025-09-17 | Iniziato | Barclays | Overweight |
| 2025-09-15 | Iniziato | Leerink Partners | Outperform |
| 2025-08-21 | Ripresa | Jefferies | Buy |
| 2025-07-30 | Ripresa | Raymond James | Strong Buy |
| 2025-07-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-11-26 | Reiterato | H.C. Wainwright | Buy |
| 2024-10-07 | Reiterato | H.C. Wainwright | Buy |
| 2024-03-28 | Iniziato | Raymond James | Strong Buy |
| 2023-10-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-04-03 | Ripresa | Piper Sandler | Overweight |
| 2022-09-19 | Ripresa | H.C. Wainwright | Buy |
| 2022-07-12 | Iniziato | Truist | Buy |
| 2022-03-23 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-22 | Downgrade | Jefferies | Buy → Hold |
| 2021-11-19 | Iniziato | Piper Sandler | Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-01-11 | Iniziato | Credit Suisse | Outperform |
| 2021-01-06 | Iniziato | JP Morgan | Overweight |
| 2020-03-12 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Scholar Rock Holding Corp Borsa (SRRK) Ultime notizie
Scholar Rock (NASDAQ:SRRK) Reaches New 12-Month HighHere's What Happened - MarketBeat
Marantz Jing L., chief medical officer at Scholar Rock, sells $257,881 in stock - Investing.com Canada
Scholar Rock CSO Qatanani sells $373k in shares By Investing.com - Investing.com Australia
Insider Selling: Scholar Rock (NASDAQ:SRRK) Insider Sells 6,600 Shares of Stock - MarketBeat
Caryn Parlavecchio, CHRO of Scholar Rock, sells $293k in shares - Investing.com Nigeria
Insider Selling: Scholar Rock (NASDAQ:SRRK) Insider Sells 8,406 Shares of Stock - MarketBeat
Scholar Rock (NASDAQ:SRRK) General Counsel Junlin Ho Sells 8,016 Shares - MarketBeat
Scholar Rock CSO Qatanani sells $373k in shares - Investing.com
Scholar Rock Reports New Employee Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
Can Scholar Rock Holding Corporation stock sustain revenue growthEarnings Overview Summary & Verified Momentum Stock Watchlist - bollywoodhelpline.com
Scholar Rock (NASDAQ:SRRK) Insider Mo Qatanani Sells 13,112 Shares of Stock - MarketBeat
Hallal, CEO of Scholar Rock, sells $2.45 million in SRRK stock By Investing.com - Investing.com Nigeria
Two new Scholar Rock hires receive 35,200-share equity grant package - Stock Titan
Scholar Rock Holding Insider Sold Shares Worth $2,453,115, According to a Recent SEC Filing - marketscreener.com
Vaishnaw, Scholar Rock president, sells $872k in shares By Investing.com - Investing.com Nigeria
Hallal, CEO of Scholar Rock, sells $2.45 million in SRRK stock - Investing.com Australia
Insider Selling: Scholar Rock (NASDAQ:SRRK) COO Sells 16,746 Shares of Stock - MarketBeat
Insider Selling: Scholar Rock (NASDAQ:SRRK) Insider Sells 20,438 Shares of Stock - MarketBeat
Scholar Rock (NASDAQ:SRRK) CFO Vikas Sinha Sells 16,755 Shares - MarketBeat
Scholar Rock (SRRK) COO Woods sells $715k in stock By Investing.com - Investing.com Nigeria
Scholar Rock CFO Sinha sells $715k in shares By Investing.com - Investing.com Canada
Vaishnaw, Scholar Rock president, sells $872k in shares - Investing.com
Scholar Rock (SRRK) COO Woods sells $715k in stock - Investing.com
Scholar Rock CFO Sinha sells $715k in shares - Investing.com
Scholar Rock Executives Sell Shares to Cover Tax Obligations - TradingView — Track All Markets
SRRK: Barclays Maintains 'Overweight' Rating, Lowers Price Targe - GuruFocus
SRRK: Analyst Maintains Rating but Lowers Price Target to $44 | - GuruFocus
Insider Trends: Will Scholar Rock Holding Corporation stock gain from lower inflationDay Trade & Free Accurate Trade Setup Notifications - Bộ Nội Vụ
BMO Capital Maintains Scholar Rock(SRRK.US) With Buy Rating, Maintains Target Price $50 - 富途资讯
New muscle-targeting SMA drug could reach children and adults in 2026 - Stock Titan
Scholar Rock Highlights 2026 Strategic Priorities - Yahoo Finance
Peregrine Capital Management LLC Makes New $5.77 Million Investment in Scholar Rock Holding Corporation $SRRK - MarketBeat
SRRK Receives New 'Buy' Rating from Citigroup with $55 Price Tar - GuruFocus
StoneCrest Wealth Management Inc. Takes Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock (NASDAQ:SRRK) Upgraded at UBS Group - MarketBeat
Scholar Rock (NASDAQ:SRRK) Clinical Biologics In Nasdaq Composite - Kalkine Media
Is Scholar Rock Holding Corporation stock attractive after correctionWeekly Stock Report & Low Drawdown Trading Strategies - Улправда
SRRK: UBS Initiates Coverage with a 'Buy' Rating and $60 Price T - GuruFocus
UBS initiates Scholar Rock stock with Buy rating, sets $60 price target - Investing.com
Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Scholar Rock Holding Corporation (SRRK) Stock Analysis: Biotechnology Innovator with a Promising 12% Upside - DirectorsTalk Interviews
Scholar Rock jumps following Regeneron Eylea update - MSN
Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating - Seeking Alpha
Biotech focused on rare muscle diseases joins J.P. Morgan health conf - Stock Titan
Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Scholar Rock Holding Corporation $SRRK Shares Acquired by Moody Aldrich Partners LLC - MarketBeat
SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears - ts2.tech
Scholar Rock's chief commercial officer sells $171,927 in common stock - MSN
Scholar Rock Holding Corporation $SRRK Shares Bought by Voya Investment Management LLC - MarketBeat
Can Scholar Rock Holding Corporation stock weather global recessionGap Down & Expert Approved Momentum Trade Ideas - Улправда
Why Scholar Rock Holding Corporation (2QK) stock is listed among top recommendationsJuly 2025 Earnings & Fast Moving Trade Plans - DonanımHaber
Scholar Rock Holding Corp Azioni (SRRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.19%
2.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):